These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
740 related articles for article (PubMed ID: 22739038)
1. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K; Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038 [TBL] [Abstract][Full Text] [Related]
2. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial. Park DH; Chung JK; Seo DR; Lee SJ Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791 [TBL] [Abstract][Full Text] [Related]
3. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials. Wu D; Chen WQ; Li R; Wang Y Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234 [TBL] [Abstract][Full Text] [Related]
5. Diquafosol ophthalmic solution for dry eye treatment. Nakamura M; Imanaka T; Sakamoto A Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206 [TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of diquafosol for real-world dry eye patients: a prospective, open-label, non-interventional, observational study. Yamaguchi M; Nishijima T; Shimazaki J; Takamura E; Yokoi N; Watanabe H; Ohashi Y Adv Ther; 2014 Nov; 31(11):1169-81. PubMed ID: 25376447 [TBL] [Abstract][Full Text] [Related]
7. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition. Shigeyasu C; Yamada M; Akune Y; Tsubota K Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103 [TBL] [Abstract][Full Text] [Related]
8. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Takamura E; Tsubota K; Watanabe H; Ohashi Y; Br J Ophthalmol; 2012 Oct; 96(10):1310-5. PubMed ID: 22914501 [TBL] [Abstract][Full Text] [Related]
9. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye. Keating GM Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930 [TBL] [Abstract][Full Text] [Related]
10. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Hwang HS; Sung YM; Lee WS; Kim EC Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study. Kamiya K; Nakanishi M; Ishii R; Kobashi H; Igarashi A; Sato N; Shimizu K Eye (Lond); 2012 Oct; 26(10):1363-8. PubMed ID: 22878452 [TBL] [Abstract][Full Text] [Related]
12. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals. Utsunomiya T; Kawahara A; Hanada K; Yoshida A Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084 [TBL] [Abstract][Full Text] [Related]
13. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore. Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485 [TBL] [Abstract][Full Text] [Related]
14. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. Mun Y; Kwon JW; Oh JY BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156 [TBL] [Abstract][Full Text] [Related]
16. Effects of topical diquafosol pretreatment on intraoperative corneal wetting. Miyake G; Ota I; Miyake K; Zako M; Iwaki M J Cataract Refract Surg; 2014 Oct; 40(10):1682-8. PubMed ID: 25175269 [TBL] [Abstract][Full Text] [Related]
17. Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye. Koh S; Maeda N; Ikeda C; Oie Y; Soma T; Tsujikawa M; Watanabe H; Nishida K Acta Ophthalmol; 2014 Dec; 92(8):e671-5. PubMed ID: 24863298 [TBL] [Abstract][Full Text] [Related]
18. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis. Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017 [TBL] [Abstract][Full Text] [Related]
19. Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery. Lee H; Kim SM; Choi S; Seo KY; Kim EK; Kim TI Clin Exp Optom; 2017 Nov; 100(6):590-594. PubMed ID: 28222481 [TBL] [Abstract][Full Text] [Related]
20. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study. Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]